Related references
Note: Only part of the references are listed.Effectiveness of subcutaneous versus sublingual immunotherapy for allergic rhinitis: current update
Yohalakshmi Chelladurai et al.
CURRENT OPINION IN OTOLARYNGOLOGY & HEAD AND NECK SURGERY (2014)
Proteomics of bronchial biopsies: Galectin-3 as a predictive biomarker of airway remodelling modulation in omalizumab-treated severe asthma patients
Pierluigi Mauri et al.
IMMUNOLOGY LETTERS (2014)
Standardized quality (SQ) house dust mite sublingual immunotherapy tablet (ALK) reduces inhaled corticosteroid use while maintaining asthma control: A randomized, double-blind, placebo-controlled trial
Holger Mosbech et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
Use of omalizumab to improve desensitization safety in allergen immunotherapy
Desiree Larenas-Linnemann et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
Effectiveness of Subcutaneous Immunotherapy for Allergic Rhinoconjunctivitis and Asthma: A Systematic Review
Nkiruka Erekosima et al.
LARYNGOSCOPE (2014)
Eligibility for treatment with omalizumab in Italy and Germany
Roland Buhl et al.
RESPIRATORY MEDICINE (2014)
Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report
A. Wesley Burks et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Transient impact of omalizumab in pollen allergic patients undergoing specific immunotherapy
Matthias Volkmar Kopp et al.
PEDIATRIC ALLERGY AND IMMUNOLOGY (2013)
OMALIZUMAB MODULATES BRONCHIAL RETICULAR BASEMENT MEMBRANE THICKNESS AND EOSINOPHIL INFILTRATION IN SEVERE PERSISTENT ALLERGIC ASTHMA PATIENTS
A. M. Riccio et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2012)
Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs
J. Bousquet et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Asthma Severity According to Global Initiative for Asthma and Its Determinants: An International Study
Lucia Cazzoletti et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2010)
Effect of pretreatment with omalizumab on the tolerability of specific immunotherapy in allergic asthma
Marc Massanari et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision
Jan L. Brozek et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthma
M. V. Kopp et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2009)
Asthma: defining of the persistent adult phenotypes
Sally E. Wenzel
LANCET (2006)
Uncontrolled asthma: A review of the prevalence, disease burden and options for treatment
Stephen P. Peters et al.
RESPIRATORY MEDICINE (2006)
Incorporating anti-IgE (omalizumab) therapy into pulmonary medicine practice - Practice management implications
P Marcus
CHEST (2006)
Omalizumab pretreatment decreases acute reactions after rush immunotherapy for ragweed-induced seasonal allergic rhinitis
TB Casale et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment):: INNOVATE
M Humbert et al.
ALLERGY (2005)
Omalizumab rapidly decreases nasal allergic response and FcεRI on basophils
H Lin et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
The co-seasonal application of anti-IgE after preseasonal specific immunotherapy decreases ocular and nasal symptom scores and rescue medication use in grass pollen allergic children
C Rolinck-Werninghaus et al.
ALLERGY (2004)
Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990-2001
DI Bernstein et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
Can guideline-defined asthma control be achieved? The gaining optimal asthma control study
ED Bateman et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Omalizumab treatment downregulates dendritic cell Fc epsilon F-RI expression
C Prussin et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2003)
Efficacy of combination treatment with anti-IgE plus specific immunotherapy in polysensitized children and adolescents with seasonal allergic rhinitis
J Kuehr et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2002)
Share Paper
